DCF — NORTH CANYON MEDICAL CENTER
Enterprise Value: $13.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$13.7M
Enterprise Value
$2.6M
PV of Cash Flows
$11.0M
PV of Terminal Value
$17.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $55.4M | $2.7M | 5.0% | $0.0M | $0.0M |
| Year 2 | $57.0M | $3.3M | 6.0% | $0.4M | $0.4M |
| Year 3 | $58.7M | $4.0M | 7.0% | $0.9M | $0.7M |
| Year 4 | $60.5M | $4.4M | 7.0% | $1.1M | $0.8M |
| Year 5 | $62.3M | $4.7M | 8.0% | $1.3M | $0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $13.7M. Terminal value accounts for 81% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$53.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04342503445828048
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5